LUNG SQUAMOUS CELL CARCINOMA RECURRENT

This adverse event was reported 43 times

These drugs are most commonly taken by patients reporting LUNG SQUAMOUS CELL CARCINOMA RECURRENT:

# Drug Count
0 PEMBROLIZUMAB 13
1 INFLIXIMAB 10
2 METHOTREXATE SODIUM 10
3 CARBOPLATIN 9
4 METHOTREXATE 9
5 CISPLATIN 7
6 DURVALUMAB 6
7 PACLITAXEL 6
8 PACLITAXEL (AIBUMIN-BOUND) 5
9 BISOPROLOL FUMARATE 4
See all common drugs associated with LUNG SQUAMOUS CELL CARCINOMA RECURRENT

LUNG SQUAMOUS CELL CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEMIPLIMAB-RWLC 1 0.0005
1 TREMELIMUMAB 2 0.0005
2 DURVALUMAB 6 0.0003
3 VINORELBINE 1 0.0001
4 PEMBROLIZUMAB 13 0.0001
5 GEFITINIB 1 0.0001
6 PROCHLORPERAZINE MALEATE 1 0.0001
7 FEBUXOSTAT TABLETS 40 MG 1 0.0001
8 CISPLATIN 7 0.0001
9 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 1 0.0001
See all drugs enriched for association with LUNG SQUAMOUS CELL CARCINOMA RECURRENT